Compounded semaglutide and tirzepatide are back in the headlines. Learn what to verify with your pharmacist and how Peptimize helps organize your daily records.
Compounded semaglutide and tirzepatide are back in the headlines. For someone already using a GLP-1 medication, the coverage can leave a practical question unanswered: what should you actually check, and what information should you bring to your next appointment?
The useful starting point is to separate three things: the medicine you received, the instructions your clinician confirmed, and your own record of taking it. Peptimize can help organize that third part. Questions about the product and prescription belong with your pharmacist and prescriber.
The FDA’s current safety communication lists 990 adverse-event reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide, as of May 31, 2026. These figures have attracted renewed coverage this September. They are cumulative reports, not a count of newly confirmed injuries this month. [1]
A report does not establish that a medicine caused an event. The FDA also cautions that reporting is incomplete. These numbers cannot tell you the percentage of users affected or establish a fair risk comparison between products. [1]
The practical response is to bring specific questions to a qualified professional, rather than judge your own prescription from a headline or somebody else’s experience online.
Compounding involves preparing a medicine to meet an individual medical need. It can serve an important purpose when an approved product is unsuitable, such as when a patient needs a formulation without a particular ingredient. That does not make the resulting medicine FDA-approved. [2]
A generic medicine goes through an FDA approval pathway; a compounded preparation does not undergo that same premarket evaluation. A counterfeit is a separate issue involving a product falsely represented as authentic. Using these terms interchangeably can obscure the questions that matter. [1,2]
For a patient, a useful appointment question is: “What medical need does this particular preparation meet for me, and what approved alternatives should we discuss?” This article focuses on U.S. FDA guidance; availability and rules differ elsewhere.
An attractive website does not establish who dispensed a medicine. FDA’s BeSafeRx guidance recommends checking that an online pharmacy requires a prescription, provides a U.S. address and telephone number, has a licensed pharmacist available, and is licensed by the relevant state board of pharmacy. [3]
Keep the pharmacy’s contact details alongside your prescription information. If the supplier cannot clearly identify the dispensing pharmacy or connect you with a pharmacist, resolve that uncertainty before using the product. A social-media recommendation is not a substitute for those checks.
Ask the pharmacist to explain anything unfamiliar on a replacement package. This is especially useful when the packaging, instructions or measuring device differs from the previous supply. Keep the actual label available during that conversation; a remembered description may leave out the detail they need.
The FDA has documented dosing errors with compounded injectable semaglutide, including some that required hospitalization. Contributing issues included different concentrations, unfamiliar syringes and confusion between measurement units. [4]
Milligrams describe the amount of drug; milliliters describe liquid volume. Syringe markings do not, by themselves, establish how much semaglutide or tirzepatide is present. A number someone used with another vial cannot safely be transferred to yours.
Before administering a prescription that is unclear, ask your pharmacist or prescriber to confirm:
Ask for a demonstration and repeat the instructions back. Do not improvise a conversion using a forum post, an online calculator or a previous vial’s instructions. A tracking app should record the plan your clinician has confirmed, not work out a replacement prescription. [4]
Once your medication and instructions have been checked, a consistent record makes follow-up conversations more concrete. You do not need a complicated diary. Choose a few fields you can maintain and enter them honestly, including days when you forgot to record something.
Use Peptimize’s dose log to record the medication, confirmed dose and administration date. Keep a scheduled dose separate from a completed one. If you are uncertain whether a dose was taken, contact your care team for advice rather than treating an empty log as proof that you missed it.
Keep original prescription instructions and label photographs separately, somewhere you can retrieve them. Your app history and the pharmacy label serve different purposes: one describes your recorded routine, while the other identifies what was supplied.
Log side effects consistently. Alongside those entries, keep a brief note of when symptoms began, how long they lasted and whether they interrupted meals, drinking, sleep or work. This creates a clearer account than trying to summarize an entire week as “I felt bad.”
For example, “nausea began the evening after the recorded dose and interrupted dinner” gives your clinician something specific to discuss. It still does not establish the cause. Record what happened without assigning a diagnosis.
Peptimize lets you record hunger, food noise and cravings, as well as water and protein intake. Choose a consistent time for appetite entries so your own records are easier to compare. Follow any nutrition or fluid targets given by your care team.
These logs provide context for a conversation. They should not become a test of whether a medicine is genuine, strong enough or suitable. Neither a quiet appetite nor a difficult day can answer those questions.
Use weight tracking to review your recorded trend over time. Keep the question you want answered in view: perhaps your clinician wants to discuss a change in routine, symptoms or progress. Avoid turning a single reading into an instruction to change medication.
Peptimize’s inventory features can help you keep track of remaining supply and plan a refill conversation. Check actual stock and the pharmacy’s instructions too. An estimated supply date does not replace an expiry date, a beyond-use date or storage guidance.
Set aside a few minutes to review your entries and prepare a short, factual account:
You can show your Peptimize entries during the visit and keep any additional details in a separate note. If you use weekly summaries or advanced trends, treat them as a way to navigate your own logged information. A pattern on a graph still needs clinical interpretation.
If you suspect you took too much medication, contact a healthcare professional or poison service promptly; do not wait to see what your next log looks like. In the U.S., Poison Help is available at 1-800-222-1222. Call emergency services for collapse, seizures, trouble breathing or inability to wake someone. [5]
Severe or persistent abdominal pain, repeated vomiting, inability to keep fluids down, or signs of a serious allergic reaction also need urgent assessment. Bring the medication packaging and the best available account of what was taken. [5]
The most useful role for Peptimize is to make your day-to-day experience easier to recall: doses, symptoms, appetite, habits, weight and supply in an organized record. It cannot authenticate a medicine, check sterility or decide whether a compounded prescription is appropriate.
Start with a verified prescription and clear professional instructions. Then build a record that helps you explain what happened between appointments. That is a practical way to turn a confusing news cycle into a better-informed conversation with your care team.
Educational information only. Peptimize is a tracking tool and does not provide medical advice or recommend medications, doses or dose changes.
Educational content only. Nothing here is medical advice, a diagnosis, or a dosing or titration recommendation. Decisions about any medication belong with you and your prescriber.
